Laboratory of Hemodynamics and Cardiovascular Technology
Rheon Medical is revolutionizing the surgical treatment of glaucoma
EPFL spin-off Rheon Medical has developed the world’s first adjustable glaucoma drainage system, which has already been used successfully in over 250 patients in Europe. The company, based at EPFL Innovation Park, closed a CHF 5.6 million Series C funding round in December 2020 and just received the U.S. FDA’s Breakthrough Device Designation for its technology.
The First Endovascular Technology That Can Explore Capillaries
EPFL scientists have invented a technique to navigate electronic devices that are smaller than human hair inside blood vessels and reach arterioles. The next step will be conducting in vivo tests.
Congratulations Dr. Stamatia Zoi Pagoulatou !
On Friday October 30th 2020, Stamatia Zoi Pagoulatou, PhD student at LHTC, successfully defended her PhD thesis "Hemodynamics of ageing, ventricular-arterial coupling and noninvasive assessment of key hemodynamical and cardiac quantities", supervised by Prof. Nikolaos Stergiopulos.